MARKET

LQDA

LQDA

Liquidia Corporation
NASDAQ
69.35
+3.63
+5.52%
Opening 12:37 09/16 EDT
OPEN
65.67
PREV CLOSE
65.72
HIGH
69.41
LOW
65.34
VOLUME
353.38K
TURNOVER
--
52 WEEK HIGH
93.61
52 WEEK LOW
21.15
MARKET CAP
6.21B
P/E (TTM)
50.04
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LQDA last week (0907-0911)?
Weekly Report · 2d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surrozen (SRZN), Liquidia Technologies (LQDA) and Universal Health (UHS)
TipRanks · 09/09 09:50
Notable Tuesday Option Activity: PSIX, IREN, LQDA
NASDAQ · 09/08 19:19
Weekly Report: what happened at LQDA last week (0831-0904)?
Weekly Report · 09/07 09:10
FDA Fast-Tracks Liquidia Drug for Painful Systemic Sclerosis Complication
Benzinga · 09/03 14:41
Liquidia Gains FDA Fast Track for YUTREPIA in Raynaud’s
TipRanks · 09/03 12:51
Liquidia granted Fast Track designation to Yutrepia inhalation powder
TipRanks · 09/03 11:35
Liquidia Receives FDA's Fast Track Designation For YUTREPIA Inhalation Powder To Treat Raynaud's Phenomenon Associated With Systemic Sclerosis
Benzinga · 09/03 11:31
More
About LQDA
Liquidia Corporation is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutic products for cardiopulmonary diseases. The Company operates within the biotechnology sector, focusing on treatments for conditions such as pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The Company operates through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enables precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is a PRINT‑engineered inhaled dry‑powder formulation of treprostinil designed to enhance deep lung delivery, improve therapeutic performance, and enable higher dose administration through a convenient inhaler.

Webull offers Liquidia Corp stock information, including NASDAQ: LQDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LQDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LQDA stock methods without spending real money on the virtual paper trading platform.